committees: corporate reporting

The Committee on Corporate Reporting (CCR) was established in June 1966 for the purpose of formulating statements and positions on all matters pertaining to financial accounting, auditing and corporate reporting, including corporate policies, practices, rules, regulations, principles and standards.

CCR is a national technical committee of the organization. CCR reviews and responds, as appropriate, to research studies, statements, pronouncements, pending legislation, proposals, etc., from domestic and international agencies and organizations, including among others, the Securities and Exchange Commission (SEC), the Financial Accounting Standards Board (FASB), the Public Company Accounting Oversight Board (PCAOB), and the International Accounting Standards Board (IASB). CCR is empowered to communicate its positions to the FEI membership, other organizations, government agencies, and other parties of interest. CCR members are traditionally Corporate Controllers of large publicly traded companies.

CCR is authorized to communicate, or present, as appropriate, positions, recommendations, statements, etc., of the Committee, provided that it has the express approval of at least two-thirds of the members of the Committee, and such statements are described as being those of CCR, as distinct from FEI statements. In accordance with FEI policy, all positions, recommendations, or statements in the name of Financial Executives International must also receive a "no-veto" decision by a majority vote of the FEI Executive Committee.

Key Committee Members:
• Chair - Arnold Hanish, Eli Lilly & Company
• Vice Chair - Ronald Olejniczak, Aetna, Inc.
• Vice Chair - Loretta Cangialosi, Pfizer, Inc.